Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    18 days ago
    Change Detected
    Summary
    The only observed change is the revision label updating from v3.3.1 to v3.3.2, with no substantive changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-27T23:41:40.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1; there are no visible changes to the study information or page design.
    Difference
    0.0%
    Check dated 2025-11-20T22:35:47.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Study status updated to Active, not recruiting with enrollment at 51, and update timestamps added/updated to reflect current activity.
    Difference
    0.8%
    Check dated 2025-11-13T16:55:29.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Substantive study information (objectives, outcomes, inclusion/exclusion criteria, and locations) remains unchanged. The observed changes appear to be minor formatting or metadata updates to the page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-30T11:24:40.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Summary: The page updates to version v3.2.0 and removes a specific resource titled “Head and neck squamous cell carcinoma.” This indicates a pruning of a resource reference while introducing a new version. If there are no other content changes, then this is a minor to moderate update.
    Difference
    0.3%
    Check dated 2025-10-01T04:08:11.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    - Added revision tag v3.1.0; - Removed specific resource entry for Head and neck squamous cell carcinoma and removed v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-30T03:01:29.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.